These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33594324)

  • 1. Oncogenic roles and mechanisms of lncRNA AGAP2-AS1 in human solid tumors.
    Bao Z; Zheng Q; Li L
    Am J Transl Res; 2021; 13(2):757-769. PubMed ID: 33594324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
    Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
    Front Genet; 2020; 11():1030. PubMed ID: 33101368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
    J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGAP2-AS1: An Indispensable lncRNA in Tumors.
    Chen J; Wang B
    Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
    Chen J; Peng X; Dai Y
    Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
    Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
    J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
    Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
    Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression.
    Shen S; Li K; Liu Y; Liu X; Liu B; Ba Y; Xing W
    Mol Ther Nucleic Acids; 2020 Jun; 20():331-344. PubMed ID: 32199129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated lncRNA AGAP2-AS1 contributes to pre-eclampsia as a competing endogenous RNA for JDP2 by impairing trophoblastic phenotype.
    Xu Y; Xia X; Jiang Y; Wu D; Wang S; Fu S; Yang N; Zhang Y; Sun L
    J Cell Mol Med; 2020 Apr; 24(8):4557-4568. PubMed ID: 32150333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
    Zheng Y; Lu S; Xu Y; Zheng J
    Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of vimentin and the related lncRNA network in breast cancer.
    Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
    Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles Long Non-Coding RNA AGAP2-AS1 Contributes to Cervical Cancer Cell Proliferation Through Regulating the miR-3064-5p/SIRT1 Axis.
    Li M; Wang J; Ma H; Gao L; Zhao K; Huang T
    Front Oncol; 2021; 11():684477. PubMed ID: 34796103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.
    Ji H; Wang J; Lu B; Li J; Zhou J; Wang L; Xu S; Peng P; Hu X; Wang K
    Mol Med; 2021 Feb; 27(1):10. PubMed ID: 33522895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme.
    Tian Y; Zheng Y; Dong X
    J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M2 macrophage-derived exosomal long non-coding RNA AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing microRNA-296 and elevating NOTCH2.
    Zhang F; Sang Y; Chen D; Wu X; Wang X; Yang W; Chen Y
    Cell Death Dis; 2021 May; 12(5):467. PubMed ID: 33972506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
    Zheng Z; Chen M; Xing P; Yan X; Xie B
    Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antisense long noncoding RNA AGAP2-AS1 regulates cell proliferation and metastasis in Epithelial Ovarian Cancer.
    Tingting Z; Xiaojing L; Xiaoyan T; Keqin H; Junjun Q
    J Cancer; 2020; 11(18):5318-5328. PubMed ID: 32742478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.
    Xu Q; Zhao T; Han H; Fan J; Xie W
    Thorac Cancer; 2023 Feb; 14(5):450-461. PubMed ID: 36541122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.